通过使用不同的体内实物方法评估的保护的histidine,lysine和methionine的生物可用性
S E Räisänen1, D E Wasson2, S F Cueva2
1The Pennsylvania State University, University Park, PA 16802; Department of Agricultural Sciences, University of Helsinki, FI-00014 Helsinki, Finland.
Journal of dairy science
|December 26, 2024
概括
这项研究比较了三种方法来测量奶牛中反蛋白保护的氨基酸的生物可用性. AUC和便自由氨基酸方法显示一致的结果,突出了准确测量生物可用性的挑战.
科学领域:
- 动物营养 动物营养
- 动物生理学 动物生理学
- 营养物质的新陈代谢
背景情况:
- 准确估计氨基酸生物可用性对于优化反动物饮食至关重要.
- 保护 (RP) 氨基酸旨在绕过的降解,但它们的生物可用性可能有所不同.
- 需要使用标准化方法来评估体内生物利用性.
研究的目的:
- 将三种体内方法 (AUC,PDR,FFAA) 进行比较,以估计皮保护的胺,氨酸和氨酸的生物可用性.
- 为了评估两种不同的反保护氨酸产品的生物可用性.
- 评估不同测量技术的生物可用性估计的一致性.
主要方法:
- 在复制的4x4拉丁方形设计中,使用了8头经经经的奶牛.
- 治疗包括腹腔注射水或自由氨基酸,以及注射反保护氨基酸产品.
- 使用曲线下的面积 (AUC),血剂量-反应 (PDR) 和便自由氨基酸 (FFAA) 方法评估了生物利用性.
主要成果:
- 对于反保护的甲因的相对生物利用率估计在产品之间存在差异 (43%与61%通过AUC;67%与91%通过FFAA).
- 经保护的胺和氨酸显示出不同的生物可用性 (通过AUC分别为45%和72%,通过FFAA分别为87%和75%).
- 由于技术问题,PDR方法的数据被排除在外;AUC和FFAA方法产生了可比的相对差异.
结论:
- AUC和FFAA方法提供了与预期相一致的反保护氨基酸相对生物利用率估计,与预期保持一致.
- 技术挑战影响了PDR方法,阻止了直接比较.
- 可变性和依赖于方法的差异强调了进一步研究和规范化在体内生物可用性评估的必要性,以保护反的氨基酸产品.
相关概念视频
Methods for Studying Drug Absorption: In situ
171
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
171
Methods for Studying Drug Absorption: In vitro
164
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
164
Bioavailability: Overview
2.5K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.5K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
146
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
146
Factors Influencing Bioavailability: First-Pass Elimination
5.8K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
5.8K


